ctrl K

Watchlist Price Alert

Cyclerion Therapeutics In... (CYCN)

NASDAQ: CYCN · Real-Time Price · USD

3.17

0.04 (1.28%)

At close: Jun 05, 2025, 3:59 PM

3.24

2.21%

Pre-market: Jun 06, 2025, 09:13 AM EDT

Cyclerion Therapeutics Revenue Breakdown

Period Ending	Dec 31, 2024
License Agreement Revenue	1.75M
License Agreement Revenue Growth	n/a
License Revenue	250K
License Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017	Sep 30, 2017
Selling, General, and Administrative Revenue	1.5M	1.25M	1.24M	1.28M	1.57M	1.77M	2.13M	3.36M	3.27M	3.51M	3.52M	3.52M	3.95M	4.41M	4.6M	6.24M	5.37M	7.26M	8.03M	6.63M	6.89M	7.38M	7.12M	8.92M	10.98M	8.45M	7.79M	7.53M	3.77M	2.92M	4.04M
Selling, General, and Administrative Revenue Growth	+20.35%	+0.56%	-2.97%	-18.74%	-11.12%	-16.89%	-36.52%	+2.69%	-6.76%	-0.54%	+0.11%	-10.91%	-10.45%	-4.09%	-26.28%	+16.33%	-26.15%	-9.56%	+21.22%	-3.83%	-6.69%	+3.74%	-20.22%	-18.71%	+29.91%	+8.51%	+3.41%	+99.79%	+29.21%	-27.74%	n/a
Research and Development Revenue	36K	56K	81K	105K	44K	24K	580K	886K	3.77M	4.45M	7.08M	10.22M	9.74M	10.46M	7.03M	12.05M	8.09M	12.09M	13.7M	13.79M	16.82M	20.68M	22.3M	25.76M	26.4M	22.45M	21.5M	22.25M	21.51M	24.37M	20.83M
Research and Development Revenue Growth	-35.71%	-30.86%	-22.86%	+138.64%	+83.33%	-95.86%	-34.54%	-76.52%	-15.21%	-37.16%	-30.69%	+4.88%	-6.84%	+48.72%	-41.66%	+48.96%	-33.08%	-11.76%	-0.66%	-18.01%	-18.65%	-7.23%	-13.45%	-2.44%	+17.60%	+4.43%	-3.38%	+3.43%	-11.72%	+16.97%	n/a